EQ Reports $35M Aug 2025 Placement, $50M Max Financing, $35M Mar 2026 Placement, $22.4M Net Loss, $0 Rev, $12.8M R&D, Cash Runway to 2029
Equillium, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.08
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS